We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Maastricht University Medical Center.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00368199
First Posted: August 24, 2006
Last Update Posted: January 13, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Maastricht University Medical Center
  Purpose
The purpose of the study is to determine the sensitivity and specificity of transcranial duplex scanning (TCD) and single photon emission computer tomography (SPECT) in patients suspected of having Idiopathic Parkinson Disease (PD) or Atypical Parkinson Syndromes (APS) with as golden standard the clinical diagnosis after 2-year follow-up.

Condition Phase
Parkinson's Disease Parkinsonian Syndrome Multiple System Atrophy Supranuclear Palsy, Progressive Essential Tremor Vascular Parkinsonism Drug Induced Parkinsonism Early Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diagnostic Value Transcranial Duplex Scanning and Single Photon Emission Tomography in Patients Suspected of Having Idiopathic Parkinson Disease or Atypical Parkinson Syndromes

Resource links provided by NLM:


Further study details as provided by Maastricht University Medical Center:

Biospecimen Retention:   None Retained
no biocpsicmens

Estimated Enrollment: 250
Study Start Date: September 2006
Estimated Study Completion Date: September 2010
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
250 Patients with unclear parkinsonism at the outpatient clinic
Criteria

Inclusion Criteria:

  • Patients with unclear parkinsonism at the outpatient clinic

Exclusion Criteria:

  • Known diagnosis at presentation
  • Life expectation of less than two years because of a non neurological disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00368199


Locations
Netherlands
Vlaar AMM, resident in neurology
Maastricht, PO box 5800, Netherlands, 6202 AZ
Sponsors and Collaborators
Maastricht University Medical Center
Investigators
Principal Investigator: Wim EJ Weber, MD PhD Maastricht University Medical Center
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: AMM Vlaar, University hospital Maastricht, department of neurology
ClinicalTrials.gov Identifier: NCT00368199     History of Changes
Other Study ID Numbers: 1-Vlaar
First Submitted: August 22, 2006
First Posted: August 24, 2006
Last Update Posted: January 13, 2009
Last Verified: January 2009

Keywords provided by Maastricht University Medical Center:
single photon emission computer tomography (SPECT)
transcranial sonography
transcranial duplex scanning
parkinson's disease
atypical parkinson syndromes
parkinsonism
parkinsonian
diagnostic
progressive supranuclear paralysis

Additional relevant MeSH terms:
Syndrome
Parkinson Disease
Atrophy
Essential Tremor
Parkinsonian Disorders
Multiple System Atrophy
Shy-Drager Syndrome
Supranuclear Palsy, Progressive
Parkinson Disease, Secondary
Disease
Pathologic Processes
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Pathological Conditions, Anatomical
Primary Dysautonomias
Autonomic Nervous System Diseases
Hypotension
Vascular Diseases
Cardiovascular Diseases
Ophthalmoplegia
Ocular Motility Disorders
Cranial Nerve Diseases
Tauopathies
Paralysis
Neurologic Manifestations
Eye Diseases